An Ophthalmic Safety Study of New Investigational Drug in Breast Cancer Patients

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-512161-14-00

Acronym

D853AC00001

Enrollment

Registered

2024-11-05

Start date

2025-01-14

Completion date

Unknown

Last updated

2025-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, France, Poland, Portugal, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026